Metastatic and recurrent adenocarcinoma of the uterine cervix: A long-term survival of 16 years

I. Peregrin-Alvarez, M. N. Akl, C. P. Morrow, J. F. Magrina

Research output: Contribution to journalArticle

Abstract

Purpose of investigation: Recurrent metastatic adenocarcinoma of the cervix is associated with an extremely poor prognosis. Treatment options for recurrent disease are limited and cure is extremely rare. Case report: We report a case of a 43-year-old patient with Stage IB adenocarcinoma of the cervix. She had multiple metastatic recurrence episodes salvaged with several radical surgeries, external and intraoperative irradiation, and chemotherapy over a survival period of 16 years. Conclusion: We conclude that long-term multi-modal salvage treatment may achieve longer survival in rare cases with recurrent metastatic adenocarcinoma of the cervix.

Original languageEnglish (US)
Pages (from-to)333-335
Number of pages3
JournalEuropean Journal of Gynaecological Oncology
Volume31
Issue number3
StatePublished - 2010

Fingerprint

Cervix Uteri
Adenocarcinoma
Survival
Salvage Therapy
Recurrence
Drug Therapy
Therapeutics

Keywords

  • Long-term survival
  • Metastatic adenocarcinoma
  • Recurrent adenocarcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Peregrin-Alvarez, I., Akl, M. N., Morrow, C. P., & Magrina, J. F. (2010). Metastatic and recurrent adenocarcinoma of the uterine cervix: A long-term survival of 16 years. European Journal of Gynaecological Oncology, 31(3), 333-335.

Metastatic and recurrent adenocarcinoma of the uterine cervix : A long-term survival of 16 years. / Peregrin-Alvarez, I.; Akl, M. N.; Morrow, C. P.; Magrina, J. F.

In: European Journal of Gynaecological Oncology, Vol. 31, No. 3, 2010, p. 333-335.

Research output: Contribution to journalArticle

Peregrin-Alvarez, I, Akl, MN, Morrow, CP & Magrina, JF 2010, 'Metastatic and recurrent adenocarcinoma of the uterine cervix: A long-term survival of 16 years', European Journal of Gynaecological Oncology, vol. 31, no. 3, pp. 333-335.
Peregrin-Alvarez, I. ; Akl, M. N. ; Morrow, C. P. ; Magrina, J. F. / Metastatic and recurrent adenocarcinoma of the uterine cervix : A long-term survival of 16 years. In: European Journal of Gynaecological Oncology. 2010 ; Vol. 31, No. 3. pp. 333-335.
@article{34eff0cebb2842aa9c8b29e307e2b74e,
title = "Metastatic and recurrent adenocarcinoma of the uterine cervix: A long-term survival of 16 years",
abstract = "Purpose of investigation: Recurrent metastatic adenocarcinoma of the cervix is associated with an extremely poor prognosis. Treatment options for recurrent disease are limited and cure is extremely rare. Case report: We report a case of a 43-year-old patient with Stage IB adenocarcinoma of the cervix. She had multiple metastatic recurrence episodes salvaged with several radical surgeries, external and intraoperative irradiation, and chemotherapy over a survival period of 16 years. Conclusion: We conclude that long-term multi-modal salvage treatment may achieve longer survival in rare cases with recurrent metastatic adenocarcinoma of the cervix.",
keywords = "Long-term survival, Metastatic adenocarcinoma, Recurrent adenocarcinoma",
author = "I. Peregrin-Alvarez and Akl, {M. N.} and Morrow, {C. P.} and Magrina, {J. F.}",
year = "2010",
language = "English (US)",
volume = "31",
pages = "333--335",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "3",

}

TY - JOUR

T1 - Metastatic and recurrent adenocarcinoma of the uterine cervix

T2 - A long-term survival of 16 years

AU - Peregrin-Alvarez, I.

AU - Akl, M. N.

AU - Morrow, C. P.

AU - Magrina, J. F.

PY - 2010

Y1 - 2010

N2 - Purpose of investigation: Recurrent metastatic adenocarcinoma of the cervix is associated with an extremely poor prognosis. Treatment options for recurrent disease are limited and cure is extremely rare. Case report: We report a case of a 43-year-old patient with Stage IB adenocarcinoma of the cervix. She had multiple metastatic recurrence episodes salvaged with several radical surgeries, external and intraoperative irradiation, and chemotherapy over a survival period of 16 years. Conclusion: We conclude that long-term multi-modal salvage treatment may achieve longer survival in rare cases with recurrent metastatic adenocarcinoma of the cervix.

AB - Purpose of investigation: Recurrent metastatic adenocarcinoma of the cervix is associated with an extremely poor prognosis. Treatment options for recurrent disease are limited and cure is extremely rare. Case report: We report a case of a 43-year-old patient with Stage IB adenocarcinoma of the cervix. She had multiple metastatic recurrence episodes salvaged with several radical surgeries, external and intraoperative irradiation, and chemotherapy over a survival period of 16 years. Conclusion: We conclude that long-term multi-modal salvage treatment may achieve longer survival in rare cases with recurrent metastatic adenocarcinoma of the cervix.

KW - Long-term survival

KW - Metastatic adenocarcinoma

KW - Recurrent adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=77954128288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954128288&partnerID=8YFLogxK

M3 - Article

C2 - 21077482

AN - SCOPUS:77954128288

VL - 31

SP - 333

EP - 335

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 3

ER -